Forget Ozempic: This Obesity-Drug Giant Grabs GLP-1 Gold
As GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Index values follow a defined daily schedule so investors know when to expect updates. This brief explains the publication times and how to use the data in your investing routine.
21,512 articlesAs GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Extra Space Storage wrapped up Q4 2025 with steady occupancy and disciplined capital management. This article breaks ...
A powerful lineup in 2026 could redefine Disney's earnings trajectory. This article explains how disney's 2026 film s...
Diageo slashed its dividend by half while lowering its sales outlook, highlighting renewed weakness in the U.S. premi...
Block pivots on AI, slashing 40% of jobs as it refocuses on crypto tools and fintech services. This morning minute lo...
Mercadolibre hits $14.5 billion in annual sales, marking a major milestone for Latin America's e-commerce and fintech...
Being first to a big-market shift can pay off, but it often costs tens of billions in dollars and investor confidence...
A major hedge fund recently sold a sizable LASR stake, sparking questions about the stock's future. This article brea...
Silver miners often move with the metal itself. Here's shares Hecla Mining climbed as silver trades fluctuated, but s...
Investors wonder whether Intuitive Surgical stock is worth the risk in today’s market. This comprehensive guide weigh...
When a solar stock down year meets a bold 75 million bet on Enphase Energy, investors gain a rare glimpse into how co...
Kraft Heinz pauses its planned breakup after a string of profit slips and a Berkshire Hathaway stake-shift. The move ...